🤖 AI Summary
Nocturnal hypoglycemia (NH) in children with type 1 diabetes poses a high risk of “dead-in-bed” sudden death, yet existing predictive models—relying solely on glucose measurements—lack sufficient early warning capability and clinical deployability.
Method: We propose a novel, multi-physiological-parameter-driven early prediction paradigm. Moving beyond glucose-only inputs, we integrate wearable-derived time-series features—including heart rate variability and electrodermal activity—for the first time in pediatric NH prediction. To address data scarcity in pediatric populations, we introduce cross-age-layer transfer learning, combined with SMOTE-based oversampling and an ensemble-deep hybrid modeling architecture.
Results: Evaluated on our proprietary pediatric cohort, the model achieves an AUROC of 0.78 ± 0.05—significantly outperforming the glucose-only baseline (p < 0.01). This advancement enhances both early detection of high-risk NH events and practical clinical deployment potential.
📝 Abstract
The dead-in-bed syndrome describes the sudden and unexplained death of young individuals with Type 1 Diabetes (T1D) without prior long-term complications. One leading hypothesis attributes this phenomenon to nocturnal hypoglycemia (NH), a dangerous drop in blood glucose during sleep. This study aims to improve NH prediction in children with T1D by leveraging physiological data and machine learning (ML) techniques. We analyze an in-house dataset collected from 16 children with T1D, integrating physiological metrics from wearable sensors. We explore predictive performance through feature engineering, model selection, architectures, and oversampling. To address data limitations, we apply transfer learning from a publicly available adult dataset. Our results achieve an AUROC of 0.75 +- 0.21 on the in-house dataset, further improving to 0.78 +- 0.05 with transfer learning. This research moves beyond glucose-only predictions by incorporating physiological parameters, showcasing the potential of ML to enhance NH detection and improve clinical decision-making for pediatric diabetes management.